Author: admin

8thMarch 2019   Biotherapy Services Limited Exciting Update RAPID-1 Diabetic Foot Ulcer [RAPID-1DFU] Randomised Controlled Trial   The Board and Executive Management Team are delighted to announce that the treatment of patients has commenced on the RAPID-1DFU trial. The RAPID Biodynamic Haematogel treatment is the first-in-class, medicinal product under development for the...

    Biotherapy Services Limited   MHRA approves the RAPID-1DFU clinical trial  Company is progressing as planned towards Q1/2019 clinical trials. 8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement...

Biotherapy Services Limited   MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment.   Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018   For further information,...